Sign up below to receive updates on the upcoming opioid use disorder clinical guidance.
POATSP Education and Training Pathway
The BC Centre on Substance Use’s (BCCSU) comprehensive education and training program provides the tools for prescribing oral opioid agonist treatment (buprenorphine/naloxone, methadone, and slow-release oral morphine) and injectable opioid agonist treatment (hydromorphone and diacetylmorphine).
A detailed review of the program’s impacts can be found in the BCCSU Annual Education Report.
In June 2017, the BC Centre on Substance Use (BCCSU) became responsible for the education and training pathway for the prescribing of OAT.
While the BCCSU is mandated to provide the education and training pathway for prescribing OAT and clinical care guidance for prescribers, the Colleges continue to regulate health care professionals to ensure patient safety.
The education and training pathway
There are three components to the education and training pathway for prescribing opioid agonist treatment (OAT) medications:
For further discipline-specific information about the education and training pathway to prescribe OAT medications, visit:
- Physicians and nurse practitioners’ education and training pathway
- Registered nurses and registered psychiatric nurses’ education and training pathway
The online component is free and available to anyone interested in learning about opioid use disorder care. For general learners, it is not necessary to complete the workbook and preceptorship.
There are two online courses:
- Register now: POATSP Online Course
- Audience: Family physicians, specialists, nurse practitioners, pharmacists, and other health care professionals in BC
- Register now: POATSP: Registered Nurses and Registered Psychiatric Nurses
- Audience: Registered nurses, registered psychiatric nurses, licensed practical nurses